• WATCH HOW THE DABRA ATHERECTOMY SYSTEM WORKS

    No Guidewire

    The DABRA catheter is an atherectomy device designed to be used without a guidewire. Most doctors question whether it's feasible until they try it and realize it works, and may contribute to its safety profile.

    Tracks True Lumen

    The DABRA catheter tends to track the true lumen even while ablating tough calcified lesions without a guidewire in front.

    Forward Cutter

    The DABRA catheter is designed as a forward cutting device. It tends to spare the vessel wall from damage, which improves safety and lowers the rate of perforation and subintimal penetration.

    PRODUCT DETAILS

    The DABRA Catheter is a forward-cutter, designed to ablate a channel through a vascular blockage. DABRA is a high fill-factor liquid filled 1.5mm catheter which transmits the laser energy to molecularly ablate plaque, turning it into its own fundamental chemistry, not showering debris downstream.

     

    The wavelength of the emitted light is the result of a pulsed high-energy electrical current that is passed through a gas mixture in what’s called an Excimer laser.

     

    DABRA catheters are disposable and packaged in a standard endovascular pouch. The DABRA Atherectomy System laser lightsource is small enough for any treatment room, intuitive to use, and uses a standard 110-volt outlet.

  • TECHNOLOGY​

    What Is An Excimer Laser?

    An XeCl laser that emits pulses of ultraviolet light at 308 nm.

    The DABRA Atherectomy System accommodates a DABRA catheter to deliver the laser energy to the arterial blockage. Operating parameter ranges for this excimer laser system are fluence between 8 and 15mJ/mm2 and pulse repetition rates between 20 and 80 pulses per second. Excimer a contraction of "excited dimer." Excimer lasers are a class of gas-discharge lasers, in which pulsed high energy electrical current is passed through a gas mixture. In excimer lasers, the mixture contains a rare gas (Ar, Kr, or Xe) and a halogen (Cl or F).The wavelength of the emitted light is determined by which rare gas-halogen pair are in the mixture.Most excimer lasers emit in the ultraviolet region, generally between 350 and 193 nm.

    Excimer Laser Development

    From 1975-1979 many scientists and institutions worked on the initial development of a family of gas lasers known as the "excimer."

    Those pioneers were with institutions including Lumonics, Lambda Physik, Avco, and Caltech. The development was initiated in part because of the short wavelength of this type of light source. Monochromatic short wavelength sources were thought to have a variety of commercial, medical, and military applications.

     

    The name excimer is a contraction of "excited dimer." The important gas molecules are rare gas halides including argon fluoride, krypton fluoride, and xenon chloride. The ultraviolet light from an excimer laser is well absorbed by biological matter and organic compounds. Rather than burning or cutting material, the excimer laser adds enough energy to disrupt the molecular bonds of the surface tissue, which effectively disintegrates in a tightly controlled manner through ablation rather than burning. These properties make excimer lasers well suited to precision micromachining organic material, or delicate surgeries such as eye surgery. At lower energy densities, the laser may also be used for dermatological disorder treatment.

     

    In the early 1980s, researchers at IBM’s T. J. Watson Research Center observed the effect of the ultraviolet excimer laser on biological materials. They found that the laser made clean precise cuts that would be ideal for delicate surgeries. Subsequent work introduced the excimer laser for use in angioplasty or atherectomy, ablating blockages in arteries.. Xenon chloride excimer lasers, having a wavelength of 308nm, can also treat a variety of dermatological conditions including psoriasis, vitiligo, atopic dermatitis, and leukoderma.

    Excimer Laser Atherectomy

    In the late 1980s, 308nm excimer laser atherectomy was developed as an alternative method of percutaneous angioplasty, with the objective of reducing the high rate of restenosis associated with other angioplasty or stenting techniques.

    Excimer laser atherectomy is a procedure that utilizes an intravascular catheter system to deliver high-energy pulsed laser light to atherosclerotic lesions, or plaque, that are causing stenosis or occlusion of native arteries, or intra-arterial stents, while producing relatively little thermal damage to the vessel wall. The pulses ablate thin sections of tissue without causing significant damage to surrounding tissue. It is thought that reduction of plaque using laser ablation could be more effective in enlarging the vessel lumen than balloon angioplasty alone. Early data from large observational registry studies published in the early 1990s provided evidence of the safety of the procedure.

     

    By 1994, Advanced Interventional Systems (AIS) had commercialized a system and gained FDA approval for the procedure. Later in the decade AIS merged with Spectranetics, Inc., which had developed an excimer for treating peripherals. There are approximately 1,000 Spectranetics lasers placed today, and thousands of excimer laser endovascular procedures are performed each year. The Ra Medical team, which includes members of the Spectranetics and AIS development teams, began developing the DABRA Atherectomy System, including the excimer laser and DABRA Catheter for ablating blockages in 2006.

  • SYSTEM SPECS

    Wavelength

    308nm

    Gas

    XeCl Mix

    Spot Size

    1.5mm

    Beam Profile

    Uniform

    Firing Device

    FootPedal

    Delivery

    150cm working length, full-fill factor, liquid-filled catheter

    Weight

    106lbs (48kg)

    Size

    14”W x 27”L x 32”H (36cm x 68cm x 82cm)

    Electrical Inputs

    120/230 VAC, 50/60Hz, 6/3A

  • ADVANTAGES

    Doctors participating in Ra Medical's FDA study share their view

  • CASE STUDIES

    Doctors talk about some of their most successful cases using the DABRA Atherectomy System

    FEATURED CASES

    World's FIRST DABRA In-Stent Restenosis Case

    Marzia Lugli, MD

    Hesperia Hospital

    April 2017

    In a series of “firsts,” Dr. Marzia Lugli performs the first DABRA In-Stent Restenosis case, in the first venous case for the DABRA Atherectomy System, in its first commercial use outside of a clinical study, in its first case in Europe. This successful case was Dr Lugli’s first time using the DABRA and she is the first female physician to use the DABRA in the world.

    In-Stent Thrombus

    Athar Ansari, MD

    California Heart & Vascular Clinic

    May 2018

    Dr. Athar Ansari is one of the most experienced with the DABRA Atherectomy System, having performed more than 130 cases as of June 2018. This was the doctor's 120th case where he tackles in-stent thrombus.

    DABRA With Buddy Wire

    Procedure Only

    The Story Behind The Case

    Anita Paggi, MD

    Ospedale Sant/Anna

    Como, Italy

    ABOVE THE KNEE

    SFA

    Ospedale Maggiore Policlinico

    Near Milan, Italy

    SFA to Popliteal

    Ospedale Maggiore Policlinico

    Near Milan, Italy

    Dr. Maurizio Moggio explains a case involving a 74-year-old patient experiencing rest pain due to an occlusion in the SFA. He says he used the laser to "recanalize" the vessel and states, "We had no problem to cross the lesion."

    Popliteal

    Athar Ansari, MD

    California Heart & Vascular Clinic

    El Centro, CA

    Listen in as Ra Medical Systems CEO and Dr. Athar Ansari discuss this case in real-time. The fluoro of the blockage is side-by-side with the fluoro of the DABRA Catheter lasing.

    BELOW THE KNEE

    Anterior Tibial Artery

    Flavio Airoldi, MD

    Multimedica, Italy

    April 2017

    Watch as the DABRA Catheter follows the true lumen of the Anterior Tibial Artery. This was Dr. Flavio Airoldi's second case using the DABRA Atherectomy System.

    Anterior Tibial Artery (Pedal Access)

    Athar Ansari, MD

    California Heart & Vascular Clinic

    El Centro, California

    May 2017

    TP Trunk To Peroneal: Procedure Only

    The Story Behind This Case

    Sandra Lopez

    Ra Medical Systems Clinical Specialist

    Cases Performed During Clinical Study

    Athar Ansari, MD, FACC

    California Heart & Vascular Clinic

    October 2016

    Dr. Ansari is an experienced user of the DABRA Atherectomy System. He's performed more than 130 cases as of June 2018. This case demonstrates how quickly and effectively DABRA catheter works for a CTO.

    Ehtisham Mahmud, MD, FACC, FSCAII

    UC San Diego Cardiovascular Clinic

    December 2012

    Dr. Mahmud explains how the DABRA catheter tends to track the true lumen in one of the most successful cases performed at UCSD during the Ra Medical FDA study.

    Ernesto Rodriguera, MD, FACC

    Excel Medical Center

    October 2016

    Dr. Rodriguera was one of the first doctors to use the DABRA Atherectomy System. He's performed 27 cases as part of the FDA study. He explains why it was one of the toughest cases.

  • DOCTOR TESTIMONIALS

    Interventional Cardiologists who participated in the DABRA Atherectomy System FDA study share their experience and the potential they see for the future.

    FEATURED TESTIMONIAL:

    Nearly a dozen doctors around the world weigh-in on the DABRA Laser System.

    Athar Ansari, MD, FACC

    California Heart & Vascular Clinic

    El Centro, California

    Ehtisham Mahmud, MD

    UC San Diego Health System's Chief of Cardiovascular Medicine

    San Diego, California

    Mitul Patel, MD

    UC San Diego Health System

    San Diego, California

    Ernesto Rodriguera, MD

    Excel Medical Center

    Tijuana, Mexico

    Raghotham Patlola, MD

    Wesley Medical Center

    Hattiesburg, Mississippi

  • PATIENT TESTIMONIALS

    Some of the very first patients share what their life was like before getting treated using the DABRA Atherectomy System, and how their life has changed dramatically one year following treatment.

    50-Year-Old Female Patient

    Excel Medical Center, Tijuana, Mexico

    Dr. Ernesto Rodriguera crossed a 10-12cm CTO in the right SFA using the DABRA Atherectomy System. The patient remains patent one year after treatment.

    84-Year-Old Male Patient

    Excel Medical Center, Tijuana, Mexico

    Doctors had performed a femoral popliteal bypass, but it reoccluded and so this patient was referred to Dr. Ernesto Rodriguera, who successfully used the DABRA Atherectomy System. The patient remains patent one year after treatment.

    68-Year-Old Male Patient

    California Heart & Vascular Clinic, El Centro, CA

    A doctor at a large hospital told this man he would never play tennis again. He had been walking with a can for more than a month when he approached Dr. Athar Ansari for a second opinion. Dr. Ansari used the DABRA Laser System to unclog his popliteal artery, and he was back on the tennis court three days later. One week later, journalist Kym McNicholas rallied against him and had him running for the ball.

  • DISTRIBUTORS

    Ra Medical Systems is currently partnered with distributors in the Netherlands and Italy.

    Netherlands

    BeNaLux and Scandanavia

    bo medical technologies engages in exclusive distribution and sales of cosmedical technology. We look at cosmetic care from a medical perspective and seek products whose effects are beyond dispute and published in leading medical journals. The portfolio consists of breakthrough devices and products for dermatologists and plastic surgeons. For more information about the DABRA Atherectomy System, contact: info@bo-medical.com

    ITALY

    All Regions

    The company was founded in 2000 from the entrepreneurial spirit of Mr. Franco Papa, who holds the position of CEO since the initial constitution and puts at the service of the Company his ability gained in the medical field since the early ’90s. For more information about the DABRA Atherectomy System,
    contact: +39 0322 772032

  • MEDIA COVERAGE

    CHEDDAR TV describes the medical device market as a $155 Billion opportunity this year, and Ra...
    Read more...
    The Innovators Network www.TheInnovators.Network Kym: What sparked your interest in innovating...
    Read more...
    by Fink Densford Medical excimer laser developer Ra Medical said it won FDA 510(k) clearance...
    Read more...
    More Posts
  • Contact Us

    Don't be afraid to reach out to learn more about the DABRA Atherectomy System.

    2070 Las Palmas Drive, Carlsbad, CA 92011
    Mon-Fri 8am - 5p PT
    1-877-635-1800
    All Posts
    ×